Why did Comcast name its cable spinoff Versant?
How are Trump tariffs impacting U.S. toy prices?
Why is the U.S. trade deficit hitting records?
What’s behind Tesla’s declining European sales?
How will OpenAI’s restructuring affect its future?
What caused Rite Aid’s second bankruptcy filing?
Why did DoorDash acquire Deliveroo and SevenRooms?
How are Canadian-U.S. trade tensions evolving?
Why are AI investments not delivering expected ROI?
Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal
benzinga.com/general/health-care/25/05/45208077/elanco-animal-health-sells-xdemvy-royalties-to-blackstone-in-295-million-deal-to-lower-debt
Elanco Animal Health Incorporated (NYSE:ELAN) on Monday announced the sale of certain future tiered royalties and commercial milestones associated with Xdemvy (lotilaner ophthalmic solution) 0.25% for the human health application of lotilaner to Blackstone Life Sciences and Blackstone…
This story appeared on benzinga.com, 2025-05-05 20:40:36.